Výsledky vyhledávání - "Christoph W. Reuter"

Prognostic value of free testosterone (FT) levels during salvage chemotherapy with carboplatin plus weekly docetaxel in metastatic castration- and docetaxel-resistant prostate cancer (mDRPC)

Autor: Christoph W. Reuter, Michael A. Morgan, Christoph von Klot, Axel S. Merseburger, Martin H Fenner, Philipp Ivanyi, Viktor Gruenwald, Arnold Ganser

Publikováno v: Journal of Clinical Oncology. 32:5084-5084

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a0a6402ddb14330b5b08a5cc983eea77
https://doi.org/10.1200/jco.2014.32.15_suppl.5084

Zobrazit plný text záznamu

Effectiveness of abiraterone as salvage therapy in patients with docetaxel- and castration-resistant prostate cancer (mDCPC) that progressed during second-line chemotherapy with carboplatin plus weekly docetaxel (DC)

Autor: Christoph W. Reuter, Michael A. Morgan, Martin Fenner, Viktor Grünwald, Arnold Ganser

Publikováno v: Journal of Clinical Oncology. 31:162-162

162 Background: Our recent data have shown that carboplatin AUC5 on d1 plus docetaxel at a dose of 35 mg/m2 iv on d1, 8, 15 every 4 weeks (q4w) is an effective salvage therapy in mDRPC. Patients (pts) who have progressive disease during DC treatment

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::30591c7659631738bbe1f0b0ff0b471e
https://doi.org/10.1200/jco.2013.31.6_suppl.162

Zobrazit plný text záznamu

Hormonal impact of salvage chemotherapy with carboplatin plus weekly docetaxel in patients with castration- and docetaxel-resistant prostate cancer (DRPC)

Autor: Christoph W. Reuter, Michael A. Morgan, Martin Fenner, Philipp Ivanyi, Viktor Grünwald, Arnold Ganser

Publikováno v: Journal of Clinical Oncology. 30:e15190-e15190

e15190 Background: Recent data suggest that carboplatin may be effective in combination with docetaxel in DRPC. Platinum(II)-complexes interfere with steroid biosynthesis lowering testosterone levels by inhibiting CYP11A1, HSD3B1,2 and CYP17A1. Metho

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f0a5d50f78983d44901273fc286744ea
https://doi.org/10.1200/jco.2012.30.15_suppl.e15190

Zobrazit plný text záznamu

Hormonal impact of salvage chemotherapy with carboplatin plus weekly docetaxel in patients with castration- and docetaxel-resistant prostate cancer (DRPC)

Autor: Christoph W. Reuter, Michael A. Morgan, Martin Fenner, Viktor Grünwald, Arnold Ganser

Publikováno v: Journal of Clinical Oncology. 30:74-74

74 Background: Recent data suggest that carboplatin may be effective in combination with docetaxel in DRPC. Platinum(II)-complexes have been shown to interfere with testosterone biosynthesis by inhibiting the cholesterol side chain cleavage enzyme (C

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::022c2928f2a47931cf8f6eb92615e26d
https://doi.org/10.1200/jco.2012.30.5_suppl.74

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání